Location History:
- Thornhill, CA (2007)
- Regina, CA (2009)
Company Filing History:
1 out of 36 
1 out of 165 
Years Active: 2007-2009
Title: The Innovative Contributions of Andrew Freywald
Introduction
Andrew Freywald is a notable inventor based in Regina, Canada. He has made significant contributions to the field of biomedical research, particularly in the modulation of cell proliferation and immune system responses. With a total of 2 patents, Freywald's work has the potential to impact the treatment of various cell proliferative disorders, including cancer.
Latest Patents
Freywald's latest patents include groundbreaking research on compounds for modulating cell proliferation. These novel styrylacrylonitrile compounds are disclosed as useful in treating a variety of cell proliferative disorders such as cancer. Additionally, he has developed methods for the modulation of the immune system. This involves the manipulation of the EphB6 receptor and its active Eph partners, allowing for regulation of T cell responses, including TCR signaling, T cell proliferation, and induction of T cell death. The methods of modulating EphB6 are described along with various therapeutic applications.
Career Highlights
Throughout his career, Freywald has worked with reputable organizations such as HSC Research and Development Limited Partnership and The Hospital for Sick Children. His work in these institutions has furthered his research and development in the biomedical field.
Collaborations
Freywald has collaborated with esteemed colleagues, including Chaim M Roifman and Thomas Grunberger. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Andrew Freywald's innovative contributions to the field of biomedical research highlight his dedication to improving treatments for cell proliferative disorders. His patents and collaborations reflect a commitment to advancing medical science and enhancing patient care.